TransMedics Group, Inc. (TMDX)
TMDX Stock Price Chart
Explore TransMedics Group, Inc. interactive price chart. Choose custom timeframes to analyze TMDX price movements and trends.
TMDX Company Profile
Discover essential business fundamentals and corporate details for TransMedics Group, Inc. (TMDX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
2 May 2019
Employees
728.00
Website
https://www.transmedics.comCEO
Waleed H. Hassanein
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
TMDX Financial Timeline
Browse a chronological timeline of TransMedics Group, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 27 Oct 2025
EPS estimate is $0.37, while revenue estimate is $144.58M.
Earnings released on 30 Jul 2025
EPS came in at $0.92 surpassing the estimated $0.48 by +91.67%, while revenue for the quarter reached $157.37M , beating expectations by +11.12%.
Earnings released on 8 May 2025
EPS came in at $0.70 surpassing the estimated $0.29 by +141.38%, while revenue for the quarter reached $143.54M , beating expectations by +16.32%.
Earnings released on 27 Feb 2025
EPS came in at $0.19 falling short of the estimated $0.22 by -13.64%, while revenue for the quarter reached $121.62M , beating expectations by +11.08%.
Earnings released on 28 Oct 2024
EPS came in at $0.12 falling short of the estimated $0.29 by -58.62%, while revenue for the quarter reached $108.76M , missing expectations by -3.04%.
Earnings released on 31 Jul 2024
EPS came in at $0.35 surpassing the estimated $0.21 by +66.67%, while revenue for the quarter reached $114.31M , beating expectations by +0.15%.
Earnings released on 30 Apr 2024
EPS came in at $0.35 surpassing the estimated $0.03 by +974.94%, while revenue for the quarter reached $96.85M , beating expectations by +15.44%.
Earnings released on 26 Feb 2024
EPS came in at $0.12 surpassing the estimated $0.02 by +500.00%, while revenue for the quarter reached $81.17M , beating expectations by +18.48%.
Earnings released on 6 Nov 2023
EPS came in at -$0.12 surpassing the estimated -$0.18 by +33.33%, while revenue for the quarter reached $66.43M , beating expectations by +35.05%.
Earnings released on 3 Aug 2023
EPS came in at -$0.03 surpassing the estimated -$0.15 by +80.00%, while revenue for the quarter reached $52.47M , beating expectations by +23.68%.
Earnings released on 1 May 2023
EPS came in at -$0.08 surpassing the estimated -$0.25 by +68.00%, while revenue for the quarter reached $41.55M , beating expectations by +15.27%.
Earnings released on 22 Feb 2023
EPS came in at -$0.21 surpassing the estimated -$0.28 by +25.00%, while revenue for the quarter reached $31.38M , beating expectations by +28.34%.
Earnings released on 3 Nov 2022
EPS came in at -$0.25 surpassing the estimated -$0.40 by +37.50%, while revenue for the quarter reached $25.68M , beating expectations by +36.07%.
Earnings released on 1 Aug 2022
EPS came in at -$0.41 falling short of the estimated -$0.32 by -28.12%, while revenue for the quarter reached $20.52M , beating expectations by +26.09%.
Earnings released on 3 May 2022
EPS came in at -$0.38 falling short of the estimated -$0.35 by -8.57%, while revenue for the quarter reached $15.88M , beating expectations by +64.37%.
Earnings released on 23 Feb 2022
EPS came in at -$0.46 falling short of the estimated -$0.43 by -6.98%, while revenue for the quarter reached $9.67M , beating expectations by +28.69%.
Earnings released on 9 Nov 2021
EPS came in at -$0.47 falling short of the estimated -$0.32 by -46.87%, while revenue for the quarter reached $5.37M , missing expectations by -33.87%.
Earnings released on 5 Aug 2021
EPS came in at -$0.39 falling short of the estimated -$0.27 by -44.44%, while revenue for the quarter reached $8.17M , beating expectations by +8.23%.
Earnings released on 4 May 2021
EPS came in at -$0.29 falling short of the estimated -$0.28 by -3.57%, while revenue for the quarter reached $7.05M , meeting expectations.
Earnings released on 2 Mar 2021
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%, while revenue for the quarter reached $7.63M .
Earnings released on 4 Nov 2020
EPS came in at -$0.19 surpassing the estimated -$0.33 by +42.42%, while revenue for the quarter reached $7.09M , missing expectations by -40.62%.
TMDX Stock Performance
Access detailed TMDX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.